TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer Prof. Nicole Normanno at IRCCS Pascale (Italy) why the center chose to bring TSO 500 HRD in-house to the laboratory. *TruSight Oncology 500 not available in Japan Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: https://www.facebook.com/illuminainc LinkedIn: https://www.linkedin.com/company/illu... Instagram: https://www.instagram.com/illuminainc/ Twitter: https://twitter.com/illumina #HRD #homologousrecombinationdeficiency #CGP #comprehensivegenomicprofiling #oncology #oncologytesting #Illumina #NGS #nextgenerationsequencing #biomarkers #pathology #TruSightOncology500 #TSO500 #TSO500HRD